What's New
What’s New with VNS Therapy™ and Pharmacoresistant Epilepsy? In this section you will find information regarding upcoming Medical Society Meetings and Presentations, the most current VNS Therapy Clinical Newsletter and new information on indications development.
Recent Developments:
- Medicare increases 2004 outpatient reimbursement rates
- New Model 102R Generator now available
- FDA approves new labeling for VNS Therapy safety in women of child bearing age
- New England Journal of Medicine article identifies genetic factor association with AED drug resistance
|
|
© Cyberonics, Inc. 2007
|